Bradley Merrill Thompson, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, was mentioned in BioWorld, in “MDMA Blasts FDA Cybersecurity Draft for Mention of Health Care Facility Networks,” by Mark McCarty. (Read the full version – subscription required.)
Following is an excerpt:
The U.S. FDA’s latest draft guidance for premarket cybersecurity considerations expands considerably on the previous edition, and suggests that the manufacturer’s cybersecurity responsibilities include security in a health care facility’s network. …
Writing for the Combination Products Coalition (CPC) was regulatory attorney Brad Thompson of Epstein Becker Green, who argued that the FDA’s Center …